It’s a competitive world out there and (NYSE) offered us things that were attractive to us,” CEO George Chamoun said during ...
Quanta Services (NYSE:PWR) saw its shares jump 10% last week following the company's positive Q4 2024 earnings report and optimistic corporate guidance for 2025. The firm reported notable ...
Vistra (NYSE:VST) experienced a notable 15% rise in its share price over the past week, amid a backdrop of mixed market conditions with the major indexes struggling to rebound. This increase coincided ...
AIM ImmunoTech Inc. plans to regain compliance with NYSE equity requirements by June 2026, focusing on oncology and antiviral advancements. The company is under scrutiny from the NYSE American for ...
16. Tempus AI (NASDAQ: TEM) specializes in AI-driven precision medicine, using clinical and molecular data to personalize cancer treatments. 17. BlackSky Technologies (NYSE: BKSY) combines ...
Billionaire investor and founder of Appaloosa Management recently increased his firm’s holdings in companies like Alibaba Group (NYSE: BABA) while drastically decreasing holdings in American companies ...
If you own THE WALT DISNEY COMPANY (NYSE: DIS) shares ... opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Sign up for our newsletter to get the latest on the ...
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New York ...
In January 2025, the Securities and Exchange Commission (the Commission) approved amendments to the minimum bid price ...
The stock market recently dipped into correction territory, which is defined as a decline of 10% to 20% from its recent peak.
After Friday's recovery rally, the markets remain cautiously optimistic and are mostly extending gains right out of the gate. All three of the major stock market averages, including the Dow Jones ...
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...